The study by Keshavaz et al. [21] included 48 RCTs and found that intravenous HA did not significantly reduce mortality, kidney failure, length of hospital stay, length of ICU stay, or blood loss compared with no albumin. The gene discussed is ALB; the disease is kidney failure.